Ben Davis

Ben Davis is currently the Director of Business Development at Vernalis since April 2004. Prior to this, Ben worked as a Research Fellow at the same company. Ben also has experience as a Structural Biologist at RiboTargets and as a Research Scientist at University College London. Ben completed their PhD at Medical Research Council UK with a thesis on "NMR Studies of Intact and Active-Site Cleaved Chymotrypsin Inhibitor 2". Ben graduated with a degree in Natural Sciences, Chemistry from the University of Cambridge.